Impact of sleep disruption on BDD symptoms and treatment response
Journal of Affective Disorders · 2024-02 · 346 · 206-213
DOI: 10.1016/j.jad.2023.11.028 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Affective Disorders, 2024-02. Verfasst von Emily E Bernstein und 8 weiteren Autor:innen. Beteiligte Einrichtung: Massachusetts General Hospital, United States of America; Harvard Medical School, United States of America. Electronic address: eebernstein@mgh.harva…. Hauptthemen laut MEDLINE: Body Dysmorphic Disorders, Sleep Initiation and Maintenance Disorders, Cognitive Behavioral Therapy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Wellcome Trust, NIMH NIH HHS, National Institute of Mental Health.
Abstract (Originalsprache)
BACKGROUND: Body dysmorphic disorder (BDD) is severe, undertreated, and relatively common. Although gold-standard cognitive behavioral therapy (CBT) for BDD has strong empirical support, a significant number of patients do not respond. More work is needed to understand BDD's etiology and modifiable barriers to treatment response. Given its high prevalence and impact on the development, maintenance, and treatment of related, frequently comorbid disorders, sleep disruption is a compelling, but not-yet studied factor. METHODS: Data were drawn from a randomized controlled trial of guided smartphone app-based CBT for BDD. Included participants were offered 12-weeks of treatment, immediately (n = 40) or after a 12-week waitlist (n = 37). Sleep disruption and BDD symptom severity were assessed at baseline, week-6, and week-12. RESULTS: Hypotheses and analysis plan were pre-registered. Two-thirds of patients reported significant insomnia symptoms at baseline. Baseline severity of sleep disruption and BDD symptoms were not related (r = 0.02). Pre-treatment sleep disruption did not predict BDD symptom reduction across treatment, nor did early sleep improvements predict greater BDD symptom improvement. Early BDD symptom improvement also did not predict later improvements in sleep. LIMITATIONS: Limitations include the small sample, restricted ranges of BDD symptom severity and treatment response, and few metrics of sleep disruption. CONCLUSIONS: Although insomnia was disproportionately high in this sample and both BDD symptoms and sleep improved in treatment, results suggest sleep and BDD symptoms may function largely independent of one another. More work is encouraged to replicate and better understand findings as well as potential challenges and benefits of addressing sleep in BDD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Massachusetts General Hospital, United States of America; Harvard Medical School, United States of America. Electronic address: eebernstein@mgh.harvard.edu.
- Massachusetts General Hospital, United States of America.
- Massachusetts General Hospital, United States of America; Harvard Medical School, United States of America.
- Koa Health, United Kingdom.
Förderung
- Wellcome Trust
- NIMH NIH HHS
- National Institute of Mental Health
- Hope Funds for Cancer Research
- National Institutes of Health
Zitieren
APA
Bernstein, E. E., Klare, D., Weingarden, H., Greenberg, J. L., Snorrason, I., Hoeppner, S. S., Vanderkruik, R., Harrison, O., & Wilhelm, S. (2024). Impact of sleep disruption on BDD symptoms and treatment response. Journal of Affective Disorders, 346, 206-213. https://doi.org/10.1016/j.jad.2023.11.028
Vancouver
Bernstein EE, Klare D, Weingarden H, Greenberg JL, Snorrason I, Hoeppner SS, et al. Impact of sleep disruption on BDD symptoms and treatment response. Journal of Affective Disorders. 2024;346:206-213. doi:10.1016/j.jad.2023.11.028
BibTeX
@article{Bernstein2024,
author = {Bernstein, Emily E and Klare, Dalton and Weingarden, Hilary and Greenberg, Jennifer L and Snorrason, Ivar and Hoeppner, Susanne S and Vanderkruik, Rachel and Harrison, Oliver and Wilhelm, Sabine},
title = {Impact of sleep disruption on BDD symptoms and treatment response},
journal = {Journal of Affective Disorders},
year = {2024},
volume = {346},
pages = {206--213},
doi = {10.1016/j.jad.2023.11.028}
}
EUVIMED